Percent free prostate‐specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower

Abstract

BACKGROUND.Up to 17% of men with a prostate‐specific antigen (PSA) level below the accepted prostate biopsy cutoff of 2.5 ng/mL may have prostate cancer. Because identification of these patients represents a difficult task, we assessed the ability of percent free PSA to discriminate between benign and malignant prostate biopsy outcomes in men with PSA ≤2.5 ng/mL.METHODS.Between 1999 and 2006, 543 men with a PSA ≤2.5 ng/mL were referred for initial prostate biopsy. Age, total PSA, percent free PSA, and digital rectal examination findings represented predictors of prostate cancer at biopsy in logistic regression models. The area under the receiver operating characteristics curve (AUC) quantified the discriminative ability of the predictors. The pathological characteristics of the detected cancers were assessed in individuals treated with radical prostatectomy.RESULTS.Of all, 23% had prostate cancer on biopsy, 16.5% of patients treated with radical prostatectomy had pT3 stage, and 35.6% had a pathological Gleason score of 3 + 4 or higher. The most accurate predictor of prostate cancer on biopsy was percent free PSA (0.68) versus age (0.50), total PSA (0.57), or rectal examination findings (0.58). Of patients with percent free PSA below 14%, 59% had prostate cancer. In multivariate models, percent free PSA (P < .001) and rectal examination findings (P = .001) were the only independent predictors of prostate cancer. The combined AUC of all predictors (0.69) was not significantly (P = .7) higher than that of percentage of free PSA alone (0.68).CONCLUSIONS.The risk of prostate cancer is clearly non‐negligible in patients with PSA ≤2.5 ng/mL. The percent free PSA can accurately predict the prevalence of prostate cancer at prostate biopsy in these individuals. Cancer 2008. © 2008 American Cancer Society.

Is Testosterone Treatment Good for the Prostate? Study of Safety During Long-Term Treatment

“…A further indication of the intrinsic safety of all forms of TRT was that with each preparation, the free PSA increased in proportion to the total PSA, so that the free/total ratio remained constant or increased with treatment (Table 2). Published studies indicate that a low ratio can indicate an increased risk of PCa, and may be a useful clinical index for PCa [14,15]. In this study, some reduction in this ratio was observed in those cases that developed PCa, changing from 0.23 to 0.17 between presentation and the time of diagnosis.…”

Tumor Antigen Cross‐Presentation and the Dendritic Cell: Where it All Begins?

“…In addition, tumor cells are known to secrete soluble proteins [27, 85, 86] and antigen carrying exosomes [87, 88]. However the form of tumor antigen that is captured by DCs for cross-presentation is not known.…”

Effect of Heamolysis on Prostate-Specific Antigen

“…Management of cases may be apparent provided that PSA levels are markedly over or below the cutoff value, but the state that PSA values are around the cutoff value has been a challenge for urologists [6, 7]. In such conditions little changes of PSA or its derivatives, produced by hidden factors related to either biological variation of PSA or laboratory analysis, may have inevitable effect on selecting patients for prostate biopsy [8, 9].…”